Annual accounts
Small accounts
31/12/2026Filing deadline
Made up to 31/12/2024Due 31/12/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
SAREPTA INTERNATIONAL UK LTD.
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Spaces Reading, 9 Greyfriars Road, Reading, Berkshire RG1 1NU
- Classification (2 SIC codes)
- Manufacture of pharmaceutical preparations (21.20 - SIC 2007)Wholesale of pharmaceutical goods (46.46 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 24/12/2025View PDF (8 pages)
Accounts for a small company made up to 2024-12-31
- 24/10/2025View PDF (3 pages)
Confirmation statement made on 2025-10-12 with no updates
- 10/02/2025View PDF (2 pages)
Resolutions
- 06/02/2025View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-12-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 89 days
Confirmation statement
Confirms the registry record is up to date
26/10/2026Filing deadline
Last statement 12/10/2025Due 26/10/2026
- Next statement date
- 12/10/2026
- Last statement dated
- 12/10/2025
Financial performance
The latest figures SAREPTA INTERNATIONAL UK LTD. filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£214.63K2024
109.09%vs 20232023: £-2.36M
Total Assets
£5.93M2024
-24.49%vs 20232023: £7.85M
Cash in Bank
£2.27M2024
125.38%vs 20232023: £1.01M
Total Liabilities
£5.71M2024
-44.06%vs 20232023: £10.21M
Employees
112024
-2vs 20232023: 13
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Total liabilities moved furthest, down 44.06% on 2023. See the full financial analysis for SAREPTA INTERNATIONAL UK LTD..
The full financial record
Four ways through SAREPTA INTERNATIONAL UK LTD.'s filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · +44.1% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 11 | -2 |
| 2023 | 13 | +3 |
| 2022 | 10 | 0 |
| 2021 | 10 | – |
Reported employee count increased from 10 in 2021 to 11 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
7Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 29/09/2017–21/02/2019 | 0 | |
| Director | 29/09/2017–Present | 1 | |
| Director | 29/09/2017–14/12/2017 | 0 | |
| Director | 29/09/2017–05/06/2020 | 1 | |
| Director | 14/10/2020–01/10/2021 | 0 | |
| Director | 01/03/2019–30/10/2024 | 0 | |
| Director | 01/03/2018–04/11/2019 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 12
- Since 24/10/2022
- Last 12 months
- 2
- -3 vs the year before
- Most recent filing
- 24/12/2025
- 9 months ago
What changed in the last year
- Accounts filedLatest 24/12/2025
- Confirmation statementLatest 24/10/2025
Filing timeline
- 24/12/2025View PDF (8 pages)
Accounts for a small company made up to 2024-12-31
- 24/10/2025View PDF (3 pages)
Confirmation statement made on 2025-10-12 with no updates
- 10/02/2025View PDF (2 pages)
Resolutions
- 06/02/2025View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-12-31
- 18/12/2024View PDF (8 pages)
Accounts for a small company made up to 2023-12-31
- 21/11/2024View PDF (1 pages)
Termination of appointment of Sharon Louise Standerwick as a director on 2024-10-30
- 17/10/2024View PDF (3 pages)
Confirmation statement made on 2024-10-12 with no updates
- 21/12/2023View PDF (8 pages)
Accounts for a small company made up to 2022-12-31
- 12/10/2023View PDF (3 pages)
Confirmation statement made on 2023-10-12 with no updates
- 09/06/2023View PDF (1 pages)
Registered office address changed from Hill House 1 Little New Street London EC4A 3TR United Kingdom to Spaces Reading 9 Greyfriars Road Reading Berkshire RG1 1NU on 2023-06-09
- 19/12/2022View PDF (7 pages)
Accounts for a small company made up to 2021-12-31
- 24/10/2022View PDF (3 pages)
Confirmation statement made on 2022-09-28 with no updates
See when the next accounts and confirmation statement are due
Similar companies
4 UK companies are similar to SAREPTA INTERNATIONAL UK LTD., sharing the same company status (Active), the same industry sector and activity group (Manufacture of pharmaceutical preparations) and a comparable number of employees. The 4 closest matches are shown below to help you compare competitors and industry peers.
TYPHARM LIMITED
ActiveUnit 1 39 Mahoney Green, Rackheath, Norwich NR13 6JY
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 00894611
- Incorporated
- 22/12/1966
- Employees
- 13
TECCARE GROUP LIMITED
Active6th Floor 9 Appold Street, London EC2A 2AP
- Activity
- Manufacture of pharmaceutical preparations
- Company no.
- 06185725
- Incorporated
- 27/03/2007
- Employees
- 14
PHYTOVATION LIMITED
ActiveUnit 8 / 9 Cibyn Industrial Estate, Caernarfon, Gwynedd LL55 2BD
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 05303208
- Incorporated
- 02/12/2004
- Employees
- 11
BYROM (SOUTH WALES) LIMITED
ActiveRhoose Pharmacy, 53 Fontygary Road Rhoose, South Glamorgan CF62 3DT
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 03447221
- Incorporated
- 10/10/1997
- Employees
- 13
About SAREPTA INTERNATIONAL UK LTD.
A short description of the company, written from its Companies House record.
SAREPTA INTERNATIONAL UK LTD. is a private limited company registered in the United Kingdom, based in Spaces Reading, 9 Greyfriars Road, Reading, Berkshire RG1 1NU. Companies House classifies its business as Manufacture of pharmaceutical preparations, one of 2 SIC classifications on its record. It has been on the register for 9 years.
The register currently records it as active. Its 2024 accounts report net assets of £214.63K and 11 employees.
SAREPTA INTERNATIONAL UK LTD.: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records SAREPTA INTERNATIONAL UK LTD. under 2 registered business activities: Manufacture of pharmaceutical preparations (21.20 - SIC 2007) and Wholesale of pharmaceutical goods (46.46 - SIC 2007).
SAREPTA INTERNATIONAL UK LTD. is recorded as active on the Companies House register, and has been on it since 29/09/2017.
The most recent accounts Okredo holds cover 2024 and report net assets of £214.63K, total assets of £5.93M, cash in bank of £2.27M and total liabilities of £5.71M.
The most recent document on the record is dated 24/12/2025: Accounts for a small company made up to 2024-12-31, 9 months ago.
On the current registry record, accounts are due by 31/12/2026 and the next confirmation statement is due by 26/10/2026.
Companies House lists 7 officers (1 currently in post) and 0 people with significant control.